Paper39693187
Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China.
Yang J and 14 others. Hum Vaccin Immunother, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China. Papers, record 39693187. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39693187
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, China.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Papillomavirus Vaccines | Major topic |
| Electronic Health Records | Major topic |
| Papillomavirus Infections | Major topic |
| Human papillomavirus 18 | Major topic |
| Humans | |
| Female | |
| China | |
| Adolescent | |
| Adult | |
| Young Adult | |
| Cohort Studies | |
| Child | |
| Pregnancy | |
| Middle Aged | |
| Human papillomavirus 16 | |
| Adjuvants, Immunologic | |
| Pregnancy Outcome | |
| Vaccination | |
| Incidence |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22262597 | Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research. | Pharmacoepidemiol Drug Saf | 2012 | https://conductscience.org/library/papers/22262597 | PubMed |
| 2 | 19586656 | Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. | Lancet | 2009 | https://conductscience.org/library/papers/19586656 | PubMed |
| 3 | 30229993 | Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017. | Br J Clin Pharmacol | 2018 | https://conductscience.org/library/papers/30229993 | PubMed |
| 4 | 23391600 | Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines. | Vaccine | 2013 | https://conductscience.org/library/papers/23391600 | PubMed |
| 5 | 28984053 | Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age. | Cancer Med | 2017 | https://conductscience.org/library/papers/28984053 | PubMed |
| 6 | 29440217 | Using big data to improve cardiovascular care and outcomes in China: a protocol for the CHinese Electronic health Records Research in Yinzhou (CHERRY) Study. | BMJ Open | 2018 | https://conductscience.org/library/papers/29440217 | PubMed |
| 7 | 29854103 | Applying the Concept of Nutrient-Profiling to Promote Healthy Eating and Raise Individuals' Awareness of the Nutritional Quality of their Food. | AMIA Annu Symp Proc | 2017 | https://conductscience.org/library/papers/29854103 | PubMed |
| 8 | 33271093 | Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial. | Lancet Oncol | 2020 | https://conductscience.org/library/papers/33271093 | PubMed |
| 9 | 35568189 | COVID-19 vaccination in pregnancy. | Am J Obstet Gynecol | 2022 | https://conductscience.org/library/papers/35568189 | PubMed |
| 10 | 24644063 | Pooled analysis of large and long-term safety data from the human papillomavirus-16/18-AS04-adjuvanted vaccine clinical trial programme. | Pharmacoepidemiol Drug Saf | 2014 | https://conductscience.org/library/papers/24644063 | PubMed |
| 11 | 34754439 | Influence of doctors' perception on the diagnostic status of chronic kidney disease: results from 976 409 individuals with electronic health records in China. | Clin Kidney J | 2021 | https://conductscience.org/library/papers/34754439 | PubMed |
| 12 | 29477308 | Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015. | Vaccine | 2018 | https://conductscience.org/library/papers/29477308 | PubMed |
| 13 | 37228132 | A feasibility assessment of real-world data capabilities for monitoring vaccine safety and effectiveness in China: Human papillomavirus vaccination in the Yinzhou district as a use case. | Pharmacoepidemiol Drug Saf | 2023 | https://conductscience.org/library/papers/37228132 | PubMed |
| 14 | 29030998 | Hidden biases in observational epidemiology: the case of unmeasured confounding. | BJOG | 2018 | https://conductscience.org/library/papers/29030998 | PubMed |
| 15 | 36730318 | COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data. | PLoS One | 2023 | https://conductscience.org/library/papers/36730318 | PubMed |
| 16 | 19450645 | WHO position on HPV vaccines. | Vaccine | 2009 | https://conductscience.org/library/papers/19450645 | PubMed |
| 17 | 36271052 | Thiazolidinedione use and risk of Parkinson's disease in patients with type 2 diabetes mellitus. | NPJ Parkinsons Dis | 2022 | https://conductscience.org/library/papers/36271052 | PubMed |
| 18 | 31876615 | Systematic Review and Meta-analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events. | Pediatr Infect Dis J | 2020 | https://conductscience.org/library/papers/31876615 | PubMed |
| 19 | 31305011 | Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial. | Cancer Med | 2019 | https://conductscience.org/library/papers/31305011 | PubMed |
| 20 | 25424785 | Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese girls and women aged 9 to 45 years. | Hum Vaccin Immunother | 2014 | https://conductscience.org/library/papers/25424785 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42348585 | Monitoring the safety of the adjuvanted human papillomavirus vaccine HPV-16/18-AS04 in association with pregnancy and potential immune-related diseases in China: A retrospective observational cohort study. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/42348585 | PubMed |
| 40276516 | Development and validation of identification algorithms for five autoimmune diseases using electronic health records: a retrospective cohort study in China. | Front Immunol | 2025 | https://conductscience.org/library/papers/40276516 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39693187
GET https://conductscience.org/api/papers/v1/39693187/references?page=2